CD47 and T-cell non-Hodgkin lymphoma: In the second model, Karpas-299 (a T-cell lymphoma) was co-transplanted with human PBMC (MixenoTM)31,40, with the intent to measure the PD1 blockade effect beyond just CD47 blockade as in Raji modeling.